Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- ;
- KINGS COLLEGE LONDON
- University of London
- Durham University
- Heriot Watt University
- UNIVERSITY OF VIENNA
- DURHAM UNIVERSITY
- King's College London
- University of Birmingham
- University of Newcastle
- Aston University
- Heriot-Watt University;
- Medical Research Council
- Northumbria University;
- University of Dundee;
- University of Liverpool
- University of Oxford;
- 8 more »
- « less
-
Field
-
pathway, ribosomal translational control and mitochondrial function, and their regulation by PIM kin ases, to further our understanding of PIM kinases in T cells for therapeutic targeting in autoimmune
-
-impact journal articles, particularly targeting evidence-based healthcare design and architectural research. Engage in project dissemination through workshops, conferences, and publications. Undertake
-
to characterize the epignetic landscapre of MPN and sAML, uncover the molecular mechanisms underlying disease progression and treatment resistance and identify novel therapeutic targets. You will take a lead on
-
renewable award. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of approaches including targeted genetic murine models, primary cell
-
facilely applied as a photoluminescent layer, targeting in situ detection and non-contact visualization of surface temperatures and pressures. You should hold a PhD/DPhil (or near completion*) in materials
-
of compounds that inhibit a critical protein target that will lead to drugs for currently untreated cancer types. It employs cutting-edge structure based drug design and property-based optimisation approaches
-
use computational approaches to mine natural biodiversity in gene sequences to identify engineering targets to increase lipid content and enhance the water use efficiency. The project will make use
-
targets. You will take a lead on development of computational approaches to integrate multi-omics data from patient samples, including DNA methylation, histone modifications, single-cell transcriptomics and
-
molecular therapeutics. Their ability to target challenging biological sites and modulate intracellular functions¿capabilities beyond those of traditional small molecules and biologics¿make them a promising
-
LifeArc Centre for Rare Respiratory Diseases. We are looking for someone to join our team with expertise in genome editing or gene therapeutics that shares our bold ambition to target rare respiratory